Evidence map›Paper›PMID 38653231›Full record

ArticleThe American journal of tropical medicine and hygiene2024

Increased Prevalence of Antibodies to Hepatitis E Virus in Patients with Neurocysticercosis.

Jesus Abanto, Arantxa N Sanchez Boluarte, Yesenia Castillo, Erika Perez, Herbert Saavedra, Isidro Gonzales, Javier A Bustos, Florence Abravanel, Jacques Izopet, Richie G Madden and 2 more

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in The American journal of tropical medicine and hygiene, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 4 countries.

Jesus AbantoCentro de Salud Global, Universidad Peruana Cayetano Heredia, Lima, Perú.
Arantxa N Sanchez BoluarteFacultad de Medicina, Universidad Peruana Cayetano Heredia, Lima, Perú.
Yesenia CastilloCentro de Salud Global, Universidad Peruana Cayetano Heredia, Lima, Perú.
Erika PerezCentro Básico de Investigación en Exámenes Auxiliares en Parasitosis del Sistema Nervioso Central, Instituto Nacional de Ciencias Neurológicas, Lima, Perú.
Herbert SaavedraCentro Básico de Investigación en Exámenes Auxiliares en Parasitosis del Sistema Nervioso Central, Instituto Nacional de Ciencias Neurológicas, Lima, Perú.
Isidro GonzalesCentro Básico de Investigación en Exámenes Auxiliares en Parasitosis del Sistema Nervioso Central, Instituto Nacional de Ciencias Neurológicas, Lima, Perú.
Javier A BustosCentro de Salud Global, Universidad Peruana Cayetano Heredia, Lima, Perú.
Florence AbravanelLaboratoire de Virologie, CHU Purpan, Toulouse, France.
Jacques IzopetLaboratoire de Virologie, CHU Purpan, Toulouse, France.
Richie G MaddenDepartment of Gastroenterology and Hepatology, Royal Adelaide Hospital, University of Adelaide, South Australia.
Hector H GarciaCentro de Salud Global, Universidad Peruana Cayetano Heredia, Lima, Perú.
Harry R DaltonDepartment of Gastroenterology and Hepatology, Royal Adelaide Hospital, University of Adelaide, South Australia.
Universidad Peruana Cayetano Heredia · PEInstituto Nacional de Ciencias NeurológicasHôpital Purpan · FRInstituto Nacional de Enfermedades Neoplásicas · PERoyal Adelaide Hospital · AUUniversity of Adelaide · AU

Funding

Training in Parasitic Diseases and Central Nervous System Infections in Peru.D43TW001140 · FIC · UNIVERSIDAD PERUANA CAYETANO HEREDIA · PI GARCIA, HECTOR HUGO, GILMAN, ROBERT H · 1999 to 2025
$5.7M
FIC NIH HHS D43 TW001140
6 · The paper itself

Abstract

We explored the association between serological status for hepatitis E and neurocysticercosis (NCC) in neurologic patients attending a national neurological referral center in Lima, Perú, between the years 2008 and 2012. Anti-hepatitis E antibodies were evaluated in patients with and without NCC, and a control group of rural general population. Anti-hepatitis E IgG was found in 23.8% of patients with NCC, compared with 14.3% in subjects without NCC from a general rural population (P = 0.023) and 14.4% in subjects with neurological complaints without NCC (P = 0.027). Seropositive patients had a median age of 44 years compared with 30 years in seronegative patients (P <0.001). No significant differences in sex, region of residence, or liver enzyme values were found. Seropositivity to hepatitis E was frequent in this Peruvian population and higher in patients with NCC, suggesting shared common routes of infection.

Indexed as

Hepatitis EHepatitis E virusNeurocysticercosisAdolescentAdultAgedFemaleHepatitis AntibodiesHumansImmunoglobulin GMaleMiddle AgedPeruPrevalenceSeroepidemiologic StudiesYoung AdultHepatitis AntibodiesImmunoglobulin G

Identifiers

PMID38653231
PMCPMC11154044
OpenAlexW4395034905

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.